The aim for early next year is to get 20 000 doses of this and other vaccines being developed into the three countries worst his by the haemorrhagic disease.

It’s hoped this experimental serum therapy will counter the virus that’s killed nearly seven thousand people and infected 18 000 in Guinea, Liberia and Sierra Leone.

The bodies of Ebola survivors have learned to combat the virus with antibodies in their blood that can attack it.

Doctors take a sample of their blood, remove the red blood cells and retain important antibodies to make the serum.

Ebola patients treated in the UK and the US have already received this type of treatment.

Specially trained health care workers in Liberia will administer the serum while doctors monitor how safe and effective it is.

The post Ebola serum reaches Liberia appeared first on Jean-Jacques Cornish.